ImmuCell Corporation (ICCC)
NASDAQ: ICCC · Real-Time Price · USD
10.38
-0.62 (-5.64%)
At close: Jul 2, 2026, 4:00 PM EDT
10.29
-0.09 (-0.87%)
After-hours: Jul 2, 2026, 4:10 PM EDT

ImmuCell Revenue

ImmuCell had revenue of $10.36M in the quarter ending March 31, 2026, with 28.39% growth. This brings the company's revenue in the last twelve months to $29.93M, up 9.64% year-over-year. In the year 2025, ImmuCell had annual revenue of $27.64M with 4.34% growth.

Revenue (ttm)
$29.93M
Revenue Growth
+9.64%
P/S Ratio
3.11
Revenue / Employee
$410,059
Employees
73
Market Cap
93.09M

Revenue Chart

Revenue History

Fiscal Year EndRevenueChangeGrowth
Dec 31, 202527.64M1.15M4.34%
Dec 31, 202426.49M9.02M51.63%
Dec 31, 202317.47M-1.10M-5.90%
Dec 31, 202218.57M-675.00K-3.51%
Dec 31, 202119.24M3.90M25.43%
Dec 31, 202015.34M1.62M11.80%
Dec 31, 201913.72M2.74M24.91%
Dec 31, 201810.99M555.20K5.32%
Dec 31, 201710.43M887.14K9.30%
Dec 31, 20169.54M-684.74K-6.69%
Dec 31, 201510.23M2.63M34.64%
Dec 31, 20147.60M1.59M26.46%
Dec 31, 20136.01M617.24K11.45%
Dec 31, 20125.39M278.80K5.45%
Dec 31, 20115.11M724.94K16.53%
Dec 31, 20104.39M-119.56K-2.65%
Dec 31, 20094.51M-122.55K-2.65%
Dec 31, 20084.63M-6.21M-57.31%
Dec 31, 200710.84M1.73M19.04%
Dec 31, 20069.11M-109.26K-1.19%
Dec 31, 20059.22M--

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company NameRevenue
Pelthos Therapeutics27.70M
Seer, Inc.15.17M
NeurAxis4.28M
Alps Group3.74M
Cardiff Oncology525.00K
iBio, Inc.300.00K
Revenue Rankings